August 2018

FarmaMondo SA, the world’s leader in managing paid-access to unlicensed medicines, will exclusively distribute Spectrila® via a Managed Access Program for targeted Healthcare Providers in Russia and CIS region. FarmaMondo to manage access to Spectrila® for patients with acute lymphoblastic leukemia in Russia, Georgia, Azerbaijan, Kyrgyzstan, Uzbekistan, Moldova. Spectrila® has been...